Clinical research is increasingly driven by the need to understand biological heterogeneity, identify actionable biomarkers, and link molecular mechanisms to patient outcomes. Traditional bulk and low-resolution approaches often mask clinically relevant signals, slowing discovery and translation. 10x Genomics technologies accelerate clinical research by enabling cell-resolved and spatially resolved insights at scale at earlier in the research pipeline.

A targeted Clinician Researcher Accelerator Program designed to support medically qualified clinician researchers in generating high-impact spatial and single-cell data, with dedicated support and preferential pricing to fast-track translational research.

The Clinician Researcher Accelerator Program is a limited-time initiative supporting medically qualified clinician researchers who are looking to integrate spatial transcriptomics and single-cell profiling into their research. Successful applicants will receive access to dedicated technical guidance, and preferential pricing to help generate robust pilot data for translational and clinically focused studies.

Many clinical samples including tumours, immune tissues, and biopsies, are highly heterogeneous. Bulk profiling averages signals across cell populations, obscuring rare or disease-driving cell states.

Chromium Single Cell technologies enable researchers to:

• Identify rare or pathogenic cell populations
• Characterise immune cell diversity and activation states
• Study patient-to-patient variability at cellular resolution

Clinical impact:
Earlier identification of clinically relevant subpopulations improves hypothesis generation, patient stratification strategies, and biomarker discovery.

Understanding where cells are located within tissue is critical for clinical interpretation, particularly in oncology, immunology, and pathology-driven research.

Visium Spatial Gene Expression allows researchers to:

• Map gene expression within intact tissue sections
• Correlate molecular patterns with histology
• Identify spatially distinct disease niches

Clinical impact:
Spatial context strengthens biological interpretation, supports translational relevance, and enables more compelling mechanistic narratives for grants and publications.

Discovery technologies are most powerful when paired with targeted validation in clinically relevant samples.

Xenium In Situ enables:

• High-plex, single-cell resolution spatial validation
• Direct visualisation of clinically relevant gene signatures
• Confirmation of biomarkers within preserved tissue architecture

Clinical impact:
Xenium supports the transition from discovery to validation which is a critical step for translational studies, diagnostic development, and clinical adoption.

Clinical research is often constrained by:

• Limited sample availability
• Ethical and governance considerations
• The need to justify scale and cost upfront

10x Genomics platforms are well suited to small, high-information pilot studies, allowing researchers to:

• De-risk experimental design
• Generate convincing preliminary data
• Strengthen ARC, NHMRC, and translational grant applications

Clinical impact:
High-quality pilot data reduces uncertainty and accelerates progression to larger, funded studies.

Complex clinical questions rarely have single-dimensional answers.

10x Genomics workflows support:

• Integration of transcriptomics, immune profiling, and spatial biology
• Cross-platform studies linking cell state, location, and function
• More comprehensive biological models of disease

Clinical impact:
Multi-modal data improves robustness, reproducibility, and translational relevance which is increasingly expected by reviewers and collaborators.

Clinical research demands consistency, robustness, and scalability.

10x Genomics technologies are:

• Highly standardised and widely adopted
• Supported by validated workflows and protocols
• Designed for reproducible data generation across sites

Clinical impact:
Standardisation supports multi-centre studies and facilitates collaboration between hospitals, academia, and industry.

Graduate students and early to mid-career researchers with no prior hands-on experience using 10x Genomics technologies are invited to apply for the prestigious 2026 Millennium Science – 10x Genomics Fellowship Program.
This Fellowship is designed to support researchers who are keen to adopt cutting-edge single-cell and spatial technologies in their work.

Applications close: 16 March 2026
Outcomes announced: 30 March 2026

The 2026 Fellowship Program focuses on the application of 10x Genomics technologies to FFPE samples, using one or more of the following platforms:
Chromium Single Cell
Visium Spatial 
Xenium In Situ  (NEW within the Fellowship Program!)

If you have any questions, please contact us at fellowship@mscience.com.au.

What happens when you mix Labradors, sausage dogs, Irish wolfhounds and a dash of Siberian husky fluff with spreadsheets and science? Magic, apparently. On Tuesday, July 8th, Millennium Science opened its doors (and hearts) to a pack of paws for Bring Your Dog to Work Day, and it was pawsitively 🐾 wonderful. From professional pet portraits to gourmet dog jambalaya, it was a celebration of tails, treats, and top-tier company culture.

📸 Pet Portraits with a Pro 

We kicked things off with a professional pet photographer who captured each pup in their best light. There were solo glamour shots, action shots, and – our crowning achievement – a group photo! Herding cats might be hard, but coordinating a team of dogs to pose together? That’s next-level project management.

🍖 Canine Fine Dining 

Lunch was no ordinary kibble situation. Our very own CEO Alex Szabo rolled out his signature dog jambalaya, and it was a gastronomic event for the ages (if you ask the dogs, anyway). Five-star tail wags all round.

🐕 Speed Dating, Dog Style

Let’s face it: dogs invented speed dating. Every hallway stroll turned into a social event. We saw new friendships, unexpected tail-wags, and some solid interspecies networking.

🦴 Treats, Walks & All the Love

Throughout the day, the pups enjoyed scenic walks, an abundance of pats, and doggy bags of treats. Meanwhile, the humans enjoyed what was arguably the most serotonin-boosting Tuesday of the year.

Yes, it was adorable. But Bring Your Dog to Work Day was more than just a flurry of floppy ears and furry faces – it was a reflection of the culture we live every day at Millennium Science.

Dogs are core team members here. Our Company Morale Officers are welcome in the office any day of the week, happily lounging under desks or offering cuddles to anyone. In fact, our official company mascot is none other than Lincoln, our CEO’s beloved chocolate Labrador, and they quite possibly the most popular member of the senior leadership team.

Whether you’re here for the science or the snuggles, there’s no doubt: Millennium Science is a genuinely fantastic place to work.

Pictured: Lincoln Szabo, our company mascot.

With 12 dogs, countless treats, one gourmet lunch, and a gallery of professional pet portraits, our Bring Your Dog to Work Day was a howling success, proving once again that the culture at Millennium Science is one-of-a-kind — just like our furry coworkers.

📣 Want to see more of our culture in action? 
🐾 Follow us on LinkedIn, BlueSky or X
🚀 Watch our company video 

Join the Pack – Careers at Millennium Science Page 

The rapid and accurate detection of bacteria in aquatic environments has typically been challenging due to the complexity of the natural water microbial populations. Traditional agar plate methods for analysing aquatic bacteria are subjective and laborious, and rely on being able to adequately culture bacteria.

The good news is, flow cytometers with a high sensitivity of detection provide tools for detecting and analysing microbes independent of their cultivability, as the size, number, nucleic acid content, activity and classification of bacteria can be derived from scattered light and fluorescence signals using flow cytometry. The Agilent NovoCyte flow cytometer can detect very small particles (down to 0.1 µm) with high sensitivity, and so can be applied to various microbial studies by combining multiparameter analytic capability and convenient fluidic maintenance.

In testing the flow cytometer’s capabilities, water samples from multiple environment waters were stained with either SYBR Green I or SYTOX Green I; both are fluorescent dyes which bind to nucleic acids. The instrument was cleaned prior to running samples, filtered buffers were used, and an unstained sample was run to distinguish background noise from fluorescent signal and appropriate scatter and fluorescent thresholding was undertaken.

Using the NovoCyte flow cytometer, the bacteria in natural water could be differentiated into two groups: bacteria of low nucleic acid content (LNA) and of high nucleic acid content (HNA) (Figure 1). It is broadly accepted that HNA is active bacteria, whereas LNA is inactive, dead or a dormant population.

Figure 1: Detection of bacteria in natural waters.

Total bacterial cell counts in multiple environmental waters was also quantified using the NovoCyte flow cytometer (see Table 1). Results demonstrated that natural waters contained the highest bacterial counts of the samples tested and bottled water the lowest. Furthermore, bacterial counts in still water were 10 to 100x higher than that of spring and mountain stream sources.

Table 1: Total cell counts of bacteria in various water samples.

The detection of bacteria in various water samples is essential to maintaining sanitary and healthy drinking conditions, and the NovoCyte flow cytometer can easily and efficiently detect and quantify bacteria in water from several sources. With detection sensitivity coupled to the automatic cell counts measured for each sample, the NovoCyte is an efficient instrument for this application.

Top image credit: iStock.com/stock_colors

This article was initially published in Lab+Life Scientist.